Upcoming Event: THMA Fall Pharmacy Growth Collaborative 2026

Advancing the business of pharmacy through collaboration and shared insights

Date

September 23, 2026

Read Time

2 minutes

The pharmacy landscape continues to evolve as health systems navigate new market dynamics, rising operational complexity, financial pressures, and increasing expectations to deliver both clinical and business performance.

This is why McKesson is pleased to once again participate in the 2026 THMA Fall Pharmacy Growth Collaborative, taking place October 14-16 in Boston, Massachusetts. Year after year, the event provides a valuable opportunity to connect with health system pharmacy leaders from across the country, exchange perspectives on emerging challenges and opportunities, and gain insight into the priorities shaping the future of pharmacy.

Through these conversations, we gain a deeper understanding of the realities leaders are navigating and how organizations are adapting to a rapidly evolving healthcare landscape. As pharmacy continues to play an increasingly important role in both clinical and financial performance, understanding where leaders are focusing their efforts is more important than ever.

We look forward to continuing these conversations, strengthening relationships, and learning from organizations working to advance pharmacy performance, drive innovation, and improve outcomes across their health systems. Through collaboration and shared insights, we can collectively help advance the business of pharmacy and support the evolving needs of health systems nationwide.

Brittany Ulrich, PharmD, CSP, BCBBS, examines how limited distribution drugs and payer requirements push specialty prescriptions outside the organization, eroding visibility into patient outcomes, and how Biologics by McKesson helps health systems expect more when it comes to maintaining care continuity.

Aerial view of a large warehouse complex with loading docks, trucks and intersecting roads.

Case Study: How McKesson’s Winter-Storm Playbook Kept Specialty Drugs Moving

Expect more for the business of pharmacy with a pressure-tested, multi-layered business continuity strategy.

Researcher in a laboratory looks through shelving lined with containers and supplies.

What You Should Know About the CMS Proposed 340B Payment Change

Dr. Andrew Wilson, B.S., Pharm.D., FASHP, reflects on the proposed CY 2027 OPPS rule for several outpatient drugs purchased through the 340B program, and the next phase of specialty drug margin management for the business of pharmacy.

Open laptop beside a stack of tabbed documents in a binder on a desk, with a softly blurred office background.

Top Prescribed Perspectives Reads for August

The top three Prescribed Perspectives articles most read by health systems in August.

Business professionals greet with a handshake in a modern office while colleagues stand nearby during a networking conversation.

Upcoming Event: inSPire 2026

Connect with McKesson at inSPire to help shape the future of specialty pharmacy

Healthcare professional and colleague review information on a tablet in a clinical setting.

Where Does Your Health System Fall on the Specialty and Infusion Growth Journey?

With our assessment, benchmark your progress across the specialty and infusion journey to achieve more for the business of pharmacy.

Waterfront cityscape at sunset with reflections on the water and a Ferris wheel in the distance. Provide your feedback on BizChat

Event Recap: 2026 340B Coalition Summer Conference Highlights

At this year's event, our experts engaged with health system leaders to better understand the priorities, challenges, and opportunities shaping the future of 340B.

Upcoming Event: THMA Fall Pharmacy Growth Collaborative 2026

Related Stories

Related Tags